advertising
S4 Capital Projects Marginal Drop in 2026 Net Revenue
German Publishers Reject Apple's Revised App Tracking Rules, Urge Antitrust Fine
WPP's New CEO Simplifies Ad Group to Save 500 Million Pounds by 2028
FinanceAd Giant Omnicom Posts Upbeat Quarterly Revenue on Boost From Ipg Acquisition, New Clients
Google Targeted by EU Over Online Ad Price Practices Unfair to Advertisers
Date: February 12, 2026
BRUSSELS, Feb 12 (Reuters) - EU antitrust regulators are investigating Alphabet unit Google over the sale of search advertisements in Europe, a letter to advertisers seen by Reuters showed. The...
Italy Regulator Probes Procter & Gamble Over Misleading Ads for Epilator
Date: February 12, 2026
ROME, Feb 12 (Reuters) - Italy's competition authority said on Thursday it had opened an investigation against U.S. consumer goods maker Procter & Gamble over allegedly misleading adverts for a body...
Italy Watchdog Blocks Byd Advert After Stellantis Complaint
Date: February 4, 2026
ROME, Feb 4 (Reuters) - Italy's advertising standards authority has blocked an ad campaign by Chinese EV maker BYD on defamation grounds, heeding a complaint by Franco-Italian rival Stellantis. The...
Anthropic's New AI Tools Deepen Selloff in Data Analytics and Software Stocks, Investors Say
Date: February 3, 2026
By Samuel Indyk and Danilo Masoni LONDON, Feb 3 (Reuters) - A sell-off in European software, data analytics and advertising companies accelerated on Tuesday, as updated artificial intelligence models...
Ro CEO Says Wegovy Pill Is Bringing in New Customers, Including Men
Date: January 28, 2026
By Amina Niasse NEW YORK, Jan 28 (Reuters) - Telehealth company Ro has had an influx of new customers seeking the newly launched pill version of Wegovy to lose weight, including men who have shied...
Exclusive-Novo's Wegovy and Ozempic US Advertising Spend Doubles Rival Eli Lilly, Data Shows
Date: January 28, 2026
By Harshita Mary Varghese and Patrick Wingrove Jan 28 (Reuters) - Novo Nordisk spent nearly $500 million on U.S. advertising for its GLP-1 drugs Wegovy and Ozempic in the first nine months of 2025,...